The aim of this study is to determine whether Low-molecular-weight Fucoidan (LMWF) and Sigma Fucoidan (FS), combined with GroA, will synergize in inhibition of prostate cancer cells. This evidence concerns the gene CXCL1 and Familial prostate cancer.